|
1
|
Behboudi S and Pereira SP:
Alpha-fetoprotein specific CD4 and CD8 T cell responses in patients
with hepatocellular carcinoma. World J Hepatol. 2:256–260. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Thimme R, Neagu M, Boettler T,
Neumann-Haefelin C, Kersting N, Geissler M, Makowiec F, Obermaier
R, Hopt UT, Blum HE and Spangenberg HC: Comprehensive analysis of
the alpha-fetoprotein-specific CD8+ T cell responses in patients
with hepatocellular carcinoma. Hepatology. 48:1821–1833. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Oelkrug C and Ramage JM: Enhancement of T
cell recruitment and infiltration into tumours. Clin Exp Immunol.
178:1–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Anguille S, Smits EL, Lion E, van Tendeloo
VF and Berneman ZN: Clinical use of dendritic cells for cancer
therapy. Lancet Oncol. 15:e257–e267. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bodmer WF, Browning MJ, Krausa P, Rowan A,
Bicknell DC and Bodmer JG: Tumor escape from immune response by
variation in HLA expression and other mechanisms. Ann NY Acad Sci.
690:42–49. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Kurokohchi K, Carrington M, Mann DL,
Simonis TB, Alexander-Miller MA, Feinstone SM, Akatsuka T and
Berzofsky JA: Expression of HLA class I molecules and the
transporter associated with antigen processing in hepatocellular
carcinoma. Hepatology. 23:1181–1188. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wadee AA, Paterson A, Coplan KA and Reddy
SG: HLA expression in hepatocellular carcinoma cell lines. Clin Exp
Immunol. 97:328–333. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Fujiwara K, Higashi T, Nouso K,
Nakatsukasa H, Kobayashi Y, Uemura M, Nakamura S, Sato S, Hanafusa
T, Yumoto Y, et al: Decreased expression of B7 costimulatory
molecules and major histocompatibility complex class-I in human
hepato-cellular carcinoma. J Gastroenterol Hepatol. 19:1121–1127.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Salem ML: The use of dendritic cells for
peptide-based vaccination in cancer immunotherapy. Methods Mol
Biol. 1139:479–503. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chiriva-Internati M, Liu Y, Salati E, Zhou
W, Wang Z, Grizzi F, Roman JJ, Lim SH and Hermonat PL: Efficient
generation of cytotoxic T lymphocytes against cervical cancer cells
by adeno-associated virus/human papillomavirus type 16 E7 antigen
gene transduction into dendritic cells. Eur J Immunol. 32:30–38.
2002. View Article : Google Scholar
|
|
11
|
Mahadevan M, Liu Y, You C, Luo R, You H,
Mehta JL and Hermonat PL: Generation of robust cytotoxic T
lymphocytes against prostate specific antigen by transduction of
dendritic cells using protein and recombinant adeno-associated
virus. Cancer Immunol Immunother. 56:1615–1624. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Nilsen EM, Johansen FE, Kvale D, Krajci P
and Brandtzaeg P: Different regulatory pathways employed in
cytokine-enhanced expression of secretory component and epithelial
HLA class I genes. Eur J Immunol. 29:168–179. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Brouwer RE, van der Heiden P, Schreuder
GM, Mulder A, Datema G, Anholts JD, Willemze R, Claas FH and
Falkenburg JH: Loss or downregulation of HLA class I expression at
the allelic level in acute leukemia is infrequent but functionally
relevant and can be restored by interferon. Hum Immunol.
63:200–210. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Samulski RJ, Berns KI, Tan M and Muzyczka
N: Cloning of adeno-associated virus into pBR322: Rescue of intact
virus from the recombinant plasmid in human cells. Proc Natl Acad
Sci USA. 79:2077–2081. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Morinaga T, Sakai M, Wegmann TG and
Tamaoki T: Primary structures of human alpha-fetoprotein and its
mRNA. Proc Natl Acad Sci USA. 80:4604–4608. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Devos R, Cheroutre H, Taya Y, Degrave W,
Van Heuverswyn H and Fiers W: Molecular cloning of human immune
interferon cDNA and its expression in eukaryotic cells. Nucleic
Acids Res. 10:2487–2501. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Collaco RF, Cao X and Trempe JP: A helper
virus-free packaging system for recombinant adeno-associated virus
vectors. Gene. 238:397–405. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Auricchio A, Hildinger M, O'Connor E, Gao
GP and Wilson JM: Isolation of highly infectious and pure
adeno-associated virus type 2 vectors with a single-step
gravity-flow column. Hum Gene Ther. 12:71–76. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
de la Fuente H, Cruz-Adalia A, Martinez
Del Hoyo G, Cibrián-Vera D, Bonay P, Pérez-Hernández D, Vázquez J,
Navarro P, Gutierrez-Gallego R, Ramirez-Huesca M, et al: The
leukocyte activation receptor CD69 controls T cell differentiation
through its interaction with galectin-1. Mol Cell Biol.
34:2479–2487. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zheng W, Wang QH, Feng H, Liu J, Meng HR
and Cao YM: CD4+CD25+Foxp3+ regulatory T cells prevent the
development of Th1 immune response by inhibition of dendritic cell
function during the early stage of Plasmodium yoelii infection in
susceptible BALB/c mice. Folia Parasitol (Praha). 56:242–250. 2009.
View Article : Google Scholar
|
|
21
|
Xu L, Xu W, Jiang Z, Zhang F, Chu Y and
Xiong S: Depletion of CD4 (+) CD25 (high) regulatory T cells from
tumor infiltrating lymphocytes predominantly induces Th1 type
immune response in vivo which inhibits tumor growth in adoptive
immunotherapy. Cancer Biol Ther. 8:66–72. 2009. View Article : Google Scholar
|
|
22
|
Chang CC, Ogino T, Mullins DW, Oliver JL,
Yamshchikov GV, Bandoh N, Slingluff CL Jr and Ferrone S: Defective
human leukocyte antigen class I-associated antigen presentation
caused by a novel beta2-microglobulin loss-of-function in melanoma
cells. J Biol Chem. 281:18763–18773. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ruffell B, Chang-Strachan D, Chan V,
Rosenbusch A, Ho CM, Pryer N, Daniel D, Hwang ES, Rugo HS and
Coussens LM: Macrophage IL-10 blocks CD8+ T cell-dependent
responses to chemotherapy by suppressing IL-12 expression in
intratumoral dendritic cells. Cancer Cell. 26:623–637. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chattopadhyay G and Shevach EM:
Antigen-specific induced T regulatory cells impair dendritic cell
function via an IL-10/MARCH1-dependent mechanism. J Immunol.
191:5875–5884. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Muzyczka N: Use of adeno-associated virus
as a general transduction vector for mammalian cells. Curr Top
Microbiol Immunol. 158:97–129. 1992.PubMed/NCBI
|
|
26
|
Schoenborn JR and Wilson CB: Regulation of
interferon-gamma during innate and adaptive immune responses. Adv
Immunol. 96:41–101. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Schroder K, Hertzog PJ, Ravasi T and Hume
DA: Interferon-gamma: An overview of signals, mechanisms and
functions. J Leukoc Biol. 75:163–189. 2004. View Article : Google Scholar
|
|
28
|
Ussher JE and Taylor JA: Optimized
transduction of human monocyte-derived dendritic cells by
recombinant adeno-associated virus serotype 6. Hum Gene Ther.
21:1675–1686. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Pandya J, Ortiz L, Ling C, Rivers AE and
Aslanidi G: Rationally designed capsid and transgene cassette of
AAV6 vectors for dendritic cell-based cancer immunotherapy. Immunol
Cell Biol. 92:116–123. 2014. View Article : Google Scholar
|
|
30
|
Glushakova LG, Lisankie MJ, Eruslanov EB,
Ojano-Dirain C, Zolotukhin I, Liu C, Srivastava A and Stacpoole PW:
AAV3-mediated transfer and expression of the pyruvate
dehy-drogenase E1 alpha subunit gene causes metabolic remodeling
and apoptosis of human liver cancer cells. Mol Genet Metab.
98:289–299. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cheng B, Ling C, Dai Y, Lu Y, Glushakova
LG, Gee SW, McGoogan KE, Aslanidi GV, Park M, Stacpoole PW, et al:
Development of optimized AAV3 serotype vectors: Mechanism of
high-efficiency transduction of human liver cancer cells. Gene
Ther. 19:375–384. 2012. View Article : Google Scholar :
|
|
32
|
Ling C, Lu Y, Kalsi JK, Jayandharan GR, Li
B, Ma W, Cheng B, Gee SW, McGoogan KE, Govindasamy L, et al: Human
hepatocyte growth factor receptor is a cellular coreceptor for
adeno-associated virus serotype 3. Hum Gene Ther. 21:1741–1747.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang FL, Jia SQ, Zheng SP and Ding W:
Celastrol enhances AAV1-mediated gene expression in mice adipose
tissues. Gene Ther. 18:128–134. 2011. View Article : Google Scholar
|
|
34
|
Mitchell AM, Li C and Samulski RJ: Arsenic
trioxide stabilizes accumulations of adeno-associated virus virions
at the perinuclear region, increasing transduction in vitro and in
vivo. J Virol. 87:4571–4583. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang LN, Wang Y, Lu Y, Yin ZF, Zhang YH,
Aslanidi GV, Srivastava A, Ling CQ and Ling C: Pristimerin enhances
recombinant adeno-associated virus vector-mediated transgene
expression in human cell lines in vitro and murine hepatocytes in
vivo. J Integr Med. 12:20–34. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ling CQ, Wang LN, Wang Y, Zhang YH, Yin
ZF, Wang M and Ling C: The roles of traditional Chinese medicine in
gene therapy. J Integr Med. 12:67–75. 2014. View Article : Google Scholar : PubMed/NCBI
|
